Device Registry Required to Determine Efficacy of Newest Prostate Cancer Treatment

Men diagnosed with prostate cancer in the United States now have another treatment option: high-intensity focused ultrasound (HIFU). However, the jury is out in terms of the effectiveness of the treatment, according to Weill Cornell Medicine researchers. In a paper published June 28 in JAMA, they recommend that registries should be created to generate the data and evaluate cancer control and safety.

Read full article.

Healthcare Policy & Research 402 E. 67th St. New York, NY 10065 Phone: (646) 962-8001